Navigation Links
Target of diabetes type 1 identified,,

Researchers have identified a set of cells in the pancreas that are targeted by the white blood cells// and cause diabetes type 1.

The researchers from University of Colorado at Denver and Health Sciences Center says their research is likely to change the study of diabetes autoimmunity and may also change the way other autoimmune diseases are studied.

Diabetes type 1 is a metabolic disorder that happens due to rising levels of sugar in the blood, and mostly is due to defects in insulin secretion, insulin function or both. Type 1 diabetes is caused when specific cells that produce insulin in the pancreas are destroyed.

Previously it was thought that these cells might be of different varieties that exist at different locations in the pancreas. The new research suggests that these cells that gets destroyed are nothing but parts of the insulin itself, a peptide called B:9-23. The new concept of single target leads to possibilities that targeting this single peptide should cause the diabetes to be under control.

The research also brings to light the importance of insulin in the study of diabetes, and that of the insulin gene in causing diabetes across the generations.

The study is published in the current edition of journal Nature.

Reference: University of Colorado at Denver and Health Sciences Center, news release, May 2005
'"/>




Page: 1

Related medicine news :

1. Target for obesity treatment
2. Gel Offers A More Targeted Approach
3. In Search Of A New Drug To Target Cholesterol
4. In Search Of A New Drug To Target Cholesterol
5. Gene Target For Tuberculosis Identified
6. New Vaccine Targeted At Effective Treatment Against Tuberculosis
7. Novel Technique For Targeting Small-Cell Lung Cancer
8. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
9. Doctors, Pharma Companies Targeted By CBI Raids
10. Research Targets treatment for dementia and brain injuries
11. Cancer Treatments Fall Short Of Targets
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... Livermore, California (PRWEB) , ... December 02, 2016 ... ... business professionals, proudly announces the launch of its 60-day free trial program for ... round trip shipping make the offer a truly hassle free experience. , FlexiSpot’s ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... With the ... through rehabilitation of an injury, patients must find the one that works for them. ... pain, he created a machine that worked and decided to share it with others. ...
(Date:12/2/2016)... ... 02, 2016 , ... Mediaplanet is proud to announce the ... the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and ... 6 years in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned ...
(Date:12/2/2016)... ... December 02, 2016 , ... Sourced from the Isbre Springs ... properties including its unmatched natural purity of just 6 ppm TDS (Total Dissolved Solids) ... Nothing Water has been available in several ShopRite and FoodTown stores in NJ and ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... announced today that it has raised $6.0 million in an initial round of ... Health’s conviction that patients and their caregivers can receive far better care through ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2, 2016 On Thursday, the NASDAQ ... Dow Jones Industrial Average edged 0.36% higher, to finish at ... Losses were broad based as six out of nine sectors ... reports on the following Services equities: Myriad Genetics Inc. (NASDAQ: ... ), INC Research Holdings Inc. (NASDAQ: INCR ), ...
(Date:12/2/2016)... Around the corners of world, cancer has ... land present over earth. Cancer has become one of ... life time this is because of the increasing incidence ... the steady increase in global cancer incidence with its ... costs of treatment, there is increasing interest in this ...
(Date:12/2/2016)... 2, 2016 The iShares Nasdaq Biotechnology ... following Trump,s victory early in November. Less political risk ... are now predicting an uptick in M&A activities. Today, ... see how they have fared at the last close: ... Therapeutics Inc. (NASDAQ: FOLD ), Navidea Biopharmaceuticals ...
Breaking Medicine Technology: